Good morning, everyone. Thank you for standing by, and welcome to Dialogue Health Technologies web conference to discuss our acquisition of Tictrac Limited. At this time, all participants are in a listen only mode. Following the presentation, we will conduct a question and answer session for research analysts only. Instructions will be provided for you at that time. Listeners are reminded that portions of today's call may contain forward-looking statements that reflect current views in respect to future events. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. For more information on Dialogue's risks and uncertainties related to these forward-looking statements, please refer to the company's most recent MD&A and its annual information forms dated March 22, 2022, both of which are posted on SEDAR. Les détails concernant notre acquisition seront présentés ce matin par Cherif Habib, Président Directeur Général de Dialogue, par Navaid Mansuri, Chef de la Direction Financière de Dialogue, et par Martín Blinder, Fondateur et Président Directeur Général de Tictrac. [Foreign language] Details concerning our acquisition will be presented this morning by Cherif Habib, Chief Executive Officer of Dialogue, by Navaid Mansuri, Chief Financial Officer of Dialogue, and by Martín Blinder, Founder and CEO of Tictrac. Cherif, you may begin your presentation. Merci, Mark. Bonjour à tous. Merci de vous joindre à nous aujourd'hui. [Foreign language] Good morning, everyone. Thank you for joining us today. I am very pleased to report that we've reached an agreement to acquire Tictrac Limited, adding a best-in-class wellness service to our existing offerings. This transaction is another step on our mission to help people improve their health and well-being. This transaction also follows through on the strategy that we detailed during our IPO roadshow a year ago, and represents the result of over six months of diligent work by our team. We pride ourselves in being focused, patient, and measured in all aspects of our business, and this includes acquisitions. As we've said many times, we are integrators of curated services, not asset aggregators. It was therefore important for us to proceed carefully to ensure that we had a well-thought-out integration plan. We mentioned on previous calls that we were advancing on a signed LOI, and today's announcement is the conclusion of that process. Following a comprehensive global search that led us to assess close to 140 wellness companies, we identified Tictrac as the top candidate based on its commercial focus, the breadth and depth of its wellness content, and the high quality of its product features. In fact, Tictrac scored high on many of the key attributes that we value, including all the top five features that are important for our customers in a wellness service. Not only is Tictrac's offering aligned with our roadmap, but we also quickly realized that our corporate cultures were aligned as well. Both companies are entrepreneurial and innovative, and both are laser focused on driving better health outcomes for members. We couldn't be happier with the outcome and look forward to day one with Tictrac. At the time of our IPO a year ago, we laid out Dialogue's three pillars for growth. Number one, we would follow a strategy of land and expand, adding new customers and winning a higher share of wallet by selling them more of our services. Number two, we would add and integrate new services to our IHP in order to strengthen our overall offer and provide increasing value to our customers. Number three, we would expand into new markets where we could introduce our services. We also discussed how M&A would play an important role in supporting these three pillars in helping us scale the business. Today's announcement shows that we're doing exactly that. In addition to bringing a new wellness service to our IHP, Tictrac will add more than 170 organizations and 144,000 members to Dialogue. Tictrac will also provide us with an entry point into many new markets globally, including the sizable U.K. and U.S. markets. In Germany and Canada, where Tictrac is also present, there is currently no overlap in services or customers. We emphasized many times during our quarterly calls that we wanted to acquire a company whose product could be integrated seamlessly into our IHP and complement our existing services and whose business model would be aligned with ours. I'm very proud to say that this acquisition checks all the boxes. With that said, I'd like to officially welcome the entire Tictrac team to Dialogue. We're very excited to have Tictrac's CEO, Martín Blinder, with us on the call live from London, U.K., to provide insights into the company he founded and to answer questions later on. I now turn the call over to Martín to provide an overview of Tictrac. Thank you, Cherif. It's a pleasure to be on the call with you today and to discuss the reasons why Tictrac and Dialogue are a perfect fit. Tictrac is a software as a service provider of digital health and wellness services. It combines interactive features, engaging content, and behavioral science to help users form healthy habits and live a more balanced life. Tictrac operates a subscription revenue model and serves a roster of high-quality employers and insurance customers across 11 countries. The Tictrac platform is available to customers in three different solutions. First, a ready-to-roll-out and easy-to-implement SaaS platform that can be co-branded and configured for each customer. Under this option, our team of specialists manages the content calendar, activity challenges, action plans, campaigns, engagement, and onboarding. The second is an enterprise-wide label solution that is fully configured and customized specifically for the customer. Third, an API solution that allows employers or partners to plug in a series of microservices from the wellness platform into their existing solution. Now, the science behind Tictrac is based on 10 years of research and working with some of the world's leading experts in behavioral science, including UCL Centre for Behaviour Change. Through these collaborations, we've developed a proven methodology and features that focus on education and guidance that help members adopt healthier behaviors to affect meaningful change. We call this methodology HEAL, H.E.A.L, and it underpins everything we do at Tictrac. The H is for healthier over healthy. We help people make incremental healthier steps based on their unique starting point. The E is for effort over ability. Everybody's individual ability is slightly different, so we focus on inspiring action and rewarding the effort someone puts into taking control of their wellness. The A is for action over outcomes. We aim to drive simple and effective daily solutions that make longer-term goals less daunting. The L is for lifestyle over routines. We help people find enjoyable activities and connections instead of giving them strict rules to follow. The Tictrac platform offers a broad range of content that's personalized and localized to each member. This content covers areas such as workplace wellbeing, meditation, mindfulness, musculoskeletal health, fitness plans, and nutrition. Whether members need physical or mental health solutions, we develop content to help them achieve their wellness goals. One of the areas where Tictrac and Dialogue align significantly is in member engagement. Our platform aims to drive meaningful utilization, which not only supports employees in attaining their wellness objectives, but it also helps increase ROI for the employers. Our core proposition to employers and partners is based on three sequential components. The first one is engagement. The platform regularly engages employees and members, staying top of mind through daily fresh content, the weekly fitness target, action plans, community challenges, and more. The second is insights and analytics. Through analytics, we provide employers and partners with the insights to better understand employee and member needs and their health risks. With that data, our customers can adjust their engagement initiatives, their learning and development plans, and their benefits and rewards in order to optimize their ROI. The third is enable. We enable employees to achieve better health outcomes by providing them with personalized plans and creating targeted campaigns that can drive users to specific outcomes. These three components together make up Tictrac's flywheel, a virtuous circle of value driving high utilization and consequently better health outcomes. In conclusion, I'd like to highlight how motivated the Tictrac team is to join Dialogue. While we've accomplished some amazing things as a standalone company focused on wellbeing, we were extremely impressed by Dialogue's Integrated Health Platform strategy and immediately saw working with fewer trusted partners who can bring a fully integrated digital health platform to their member communities. With similar values, cultural alignment, and a common mission to help people live healthier lives, Tictrac, Dialogue was a clear path forward for us. We strongly believe that we have found the right partner with whom to continue on our journey and are committed to raising the bar even higher for health and wellbeing globally as part of Dialogue. I'll now pass it back to Cherif, who will go over the strategic rationale and benefits of the combination. Back to you, Cherif. Thank you, Martín. The acquisition of Tictrac represents a unique opportunity to accelerate the development of Dialogue's IHP through the addition of a high margin, SaaS-based offering that's focused on digital health and wellness. More specifically, this transaction extends Dialogue's continuum of care to cover wellness and prevention all the way to diagnosis and treatment. Adding a wellness service will help improve overall member health outcomes and generate strong returns on investment for our customers and partners. Tictrac's uniquely comprehensive offering in terms of breadth and depth of content is highly complementary to Dialogue's IHP and will provide meaningful opportunities to cross-sell and upsell to existing customers and attract new ones. Tictrac's wellness service will also expand Dialogue's growth opportunities and total addressable markets. The Canadian and global corporate wellness markets are significant, but fragmented and rapidly growing. Studies show a market opportunity of more than CAD 3 billion in Canada alone. Globally, the opportunity is simply gigantic at nearly $60 billion. These amounts are not surprising given how much importance employers are placing on improving productivity and quality of life while reducing disease and absenteeism. Tictrac's wellness offering will help Dialogue drive a high level of engagement within our member base and could serve as a powerful hub to promote our other services. Tictrac's platform currently delivers leading engagement rates, with some members exhibiting monthly active user rates of more than 40%, and many of these members accessing the service at least 4 times per week. This is simply amazing, especially when compared to our engagement rates, and a testament to the flywheel that Tictrac has developed. Adding a wellness component to our IHP is key to increasing customer stickiness. As we've discussed in the past, our members mostly interact with our services when they need to address specific health issues, and those visits could be months apart. With wellness, every single day will present an opportunity to interact with Dialogue. From a business model perspective, we are adding a scalable and very well-aligned SaaS-based model. Tictrac operates on a subscription model, either through per member per month rates or through license fees, and generally structures contracts on terms lasting three to five years. This approach creates a high level of customer stickiness and revenue predictability. Their go-to-market strategy targets both employers and insurance companies, which also draws a great parallel to Dialogue. In fact, Tictrac has developed relationships with four of the largest global insurance companies, including Aviva, Allianz, Prudential, and Generali. From a financial perspective, the transaction will enhance Dialogue's profile by generating new revenue growth opportunities and improving our gross margin. We see significant synergy potential both in Canada and internationally, and we'll address this in more detail later in the presentation. From a geography perspective, Tictrac's current footprint will provide Dialogue with an entry point into new markets and a pathway to global expansion. We analyzed more than 160 markets globally to assess the potential of a global wellness program and identified seven top markets as having high strategic value in corporate wellness. Tictrac already generates revenue from five of these seven markets, including the U.S. and the U.K. Lastly, we are always looking for opportunities to deepen our bench, and the acquisition of Tictrac will allow us to add high caliber talent that is motivated to join Dialogue. Martín will continue to lead the Tictrac team and its global sales efforts while supporting the integration efforts of the Tictrac service into the Dialogue IHP. He will report directly to me. I want to take a moment to highlight one point that was particularly attractive for us and that both Tictrac and Dialogue view as a very large opportunity. In a similar way to Dialogue, Tictrac has partnered with insurance companies to extend the reach of their platform. In the case of Tictrac, these partners include some of the largest insurers globally with leadership positions in many countries and several 100 million customers combined. The opportunity to deepen our ties with these partners is meaningful, and we are excited to bring an integrated approach to the table. We can also say confidently that Tictrac saw this potential from the start and has been very enthusiastic at the possibility of approaching customers with our IHP strategy. From our experience in Canada, we know that insurers and employers place a very high value on full integration, administrative simplicity, and convenience for members. We believe that these partnerships could provide Dialogue with a scalable way to expand into new markets globally and look forward to demonstrating our value proposition and commitment to positive health outcomes to these partners. Over the last few months, we spent a lot of time understanding how our businesses would fit together, how we would integrate the platforms, and how we would go to market in Canada and internationally, and how we would structure our combined forces. We have fleshed out a strong plan and can therefore focus squarely on executing once the acquisition closes. As you have heard us mention many times before, a seamless platform is key to our success. As such, we intend to fully integrate Tictrac technology and content into Dialogue's IHP. In the first 12 months, we will work on two priorities. The first will be to launch Tictrac's wellness program in Canada, where we have already received several indications of interest from customers that saw a demo of the product. At the same time, we will realize the technical work necessary to be compliant in markets outside of Canada with the goal of offering a version of our IHP internationally. I will provide more detail on that shortly. Our second priority will be to continue operating and accelerating Tictrac's growth outside Canada with Martin leading the charge. In the following 12 months, we will focus on adding new services to both our Canadian and international IHP with a priority on capabilities that can enhance our platform overall. For international markets, it will be to capitalize on scalable services that operate in low or even no regulation environments. Beyond that, in the long term, we will introduce our IHP to new markets that possess the key attributes we've prioritized for success. With that phased approach in mind, I'd like to get more specific about our strategy and the difference in how we plan to tackle Canada versus other markets. Our Canada IHP will consist of all the virtual services that we currently offer plus the new wellness solution. Our go-to-market approach will not change in Canada. We will continue to take advantage of our fully integrated and holistic platform and our comprehensive distribution capabilities. Our international growth strategy will start with a SaaS-like bundle consisting of our wellness service and our iCBT, which are complementary to each other and can be easily scaled from one international market to the next. Over time, we will look to add other services to our global IHP, adapting to the needs of the individual markets. M&A is an important part of our strategy. As I've previously mentioned, we don't want to simply collect assets and do M&A for the sake of doing M&A. It's in large part due to our discipline and rigorous approach that we're succeeding at finding Tictrac, an asset that aligns well with our strategy and that will accelerate our entry into the wellness space. Navaid will now explain the financials of the transaction in more detail. Merci, Cherif. Bonjour à tous.[Foreign language]. I'll now provide details on Tictrac's financial performance in 2021, and our expectations for that business on a standalone basis over the next two years. By standalone, I mean the results of Tictrac's wellness offering in all markets outside of Canada. Please note that we assume a conversion rate of CAD 1.6 per GBP for 2021 and throughout the forecast period. Tictrac had GBP 2.8 million or CAD 4.5 million of ARR at the end of 2021. Based on several recent contract wins and preferred vendor designations, Tictrac's growth is set to accelerate meaningfully. We expect ARR to grow at a CAGR of 130%-150% over the next two years to a range of CAD 24 million-CAD 29 million by the end of 2023. Tictrac recorded revenue of GBP 3.3 million or CAD 5.5 million in 2021, and we expect this to grow to a range of CAD 19 million-CAD 21 million at the end of 2023. Please note the following two points for modeling purposes. Number one, Tictrac's revenue for 2021 included some one-time customer implementation fees that were recognized entirely in the first year under U.K. GAAP. This explains why the recorded revenue is higher than the ARR. Going forward, these one-time revenues will be amortized over the term of each agreement under IFRS. Number two, given that we will close the transaction partway through the second quarter, we note that approximately CAD 1.5 million-CAD 2 million of revenue will have been recognized already by Tictrac, and this will not be included in our full year P&L for 2022. Moving on to profitability, as the Tictrac business scales, we expect those margins to rise to a sustainable level of approximately 90% and be accretive to Dialogue's overall margins. From an adjusted EBITDA standpoint, Tictrac had a loss of CAD 4.5 million in 2021. We expect this loss to shrink in 2022 as the business continues to scale, and we forecast a positive adjusted EBITDA between CAD 5.5 million and CAD 7.5 million in 2023. This implies an EBITDA margin of approximately 33% at the midpoint of the range. Importantly, even prior to accounting for synergies, Tictracs scalable SaaS-like model will accelerate Dialogue's path to EBITDA breakeven. With regards to synergies, just as we were extremely diligent in preparing our integration plan, we also completed a thorough analysis of revenue and cost savings opportunities from the combined businesses. We have identified three distinct buckets from which we intend to realize gains and are sharing our expectations over the next three years. First, we have a robust opportunity to sell a wellness solution to our existing customers in Canada, as well as the new ones. Several customers that have discussed their interest in wellness in the past had the opportunity to view a demo of the Tictrac platform, and initial conversations have been very constructive. We estimate ARR from wellness of CAD 8 million-CAD 10 million by the end of 2024. Second, we have also evaluated the introduction of our iCBT to Tictrac's current pipeline of international customers in a bundle with the wellness offering. We view this potential opportunity conservatively and look at ARR of at least CAD 1 million in the medium term. There is upside here as this analysis is limited to iCBT and doesn't include the possibility of additional products internationally, which would be further additive to synergies. It also does not factor any additional growth in Tictrac's pipeline. Third, while the primary driver of this transaction is revenue synergies, we do anticipate generating some cost synergies as well. Although Tictrac operates a lean business model with a robust tech and engineering team that we intend to maintain, we can likely reallocate certain roles internally to drive a more efficient distribution of resources. Overall, we expect savings of up to CAD 1 million annually starting in 2023, as integration expenses will more than offset any savings in 2022. I now want to discuss the structure of the transaction. We acquired Tictrac for a notional price of GBP 35 million or CAD 56 million. A consideration of GBP 15 million or CAD 24 million will be paid on the closing date using cash on hand, which stood at CAD 104 million at the end of 2021. The transaction is expected to close within 30 days and is subject to customary conditions. The remaining consideration of GBP 20 million or CAD 32 million is payable upon achievement of certain revenue milestones. The agreement was defined such to align payment with the conversion of Tictrac's pipeline to ARR through to March 31, 2023. At its maximum, which would occur when Tictrac reaches a cumulative ARR of GBP 9 million, the earn-out consideration would be paid 54% in cash and 46% in common shares of Dialogue valued at a minimum price of CAD 8.43 a share. In the transaction's most simplistic form, should no earn-out milestones be achieved, we are acquiring a business with GBP 2.8 million of high-margin ARR for GBP 15 million, representing a multiple of 5.3x. In a scenario where the full earn-out is paid, the multiple would drop to 3.9x. Any upside to ARR beyond GBP 9 million would result in an even lower transaction multiple. Of note, we did not factor the synergies I mentioned earlier, which when realized, would have a further favorable impact on these deal metrics. Thank you for attending today's presentation. We will now open the floor for questions. Merci, Navaid. Thank you, Navaid. To ask a question, please raise your hand using the menu item in your Zoom interface. As a reminder, and to provide an opportunity for everyone to participate, we ask that you please limit yourself to two questions. You may rejoin the queue if you have any additional points to address. Lastly, we ask that you please enable your cameras only when you are called upon for your turn. The first question comes from Jérôme Dubreuil at Desjardins Securities. Merci. Thanks for taking my question. First question, obviously first congrats on the transaction. Really easy to see how the product fits into your offering. Yeah, first question I have here is, let's assume in the ARR synergy target right now in terms of cross-sell and attach rate and what would be the expected timeline for these? Yeah. As I talked about, we've done a robust analysis of the synergy opportunities of cross-selling the wellness service for our existing base and to new customers just within Canada alone. We're expecting revenue synergies of CAD 8 million-CAD 10 million in the next three years. Great. Second question would be, obviously the growth on Tictrac was noticeable as well. Just wondering what were the main drivers of this growth really within Tictrac. Was this mostly domestic or international expansion? Martín, I'll let you answer this one. Our growth is coming internationally. We're seeing a real growth in the need for digital wellness services from workplace wellbeing, which has grown significantly as a result of COVID and lockdown, through to mental wellbeing, physical wellbeing and beyond. The main growth is really coming from both insured, but also large employers who are taking on these services on their own. Great. Thanks, and congrats again. Thank you. Thank you, Jerome. The next question is from Scott Fletcher at CIBC Capital Markets. Hey, good morning, and congrats on the deal. I agree with Jerome. It seems easy to see how it fits. I also have sort of a follow-up, maybe for Martin. Can you give us an idea of how much of the business right now is coming from insurance, from the insurance relationships versus sort of the direct business? Yeah. It's a bit intertwined because many of the employers that we service are also through insurers. Our focus, you know, historically had been driven through insurers. About a year and a half ago, we started to expand directly working with employers. The distribution of revenues will diversify as a result of some of the pipeline and new clients that we've recently won that are large employers that range anywhere from, say, five and in some cases to 100,000 employees. We see a real balancing off of revenue across both insurers and employers. The insurers that are in the world. The employer segment is continuing to grow, but the majority of it is coming from insurers. Okay, thanks. Maybe, can I ask a similar question on the geographic mix? If they're mostly, yeah, just curious on how it breaks down broadly. Yeah, certainly. We've got a considerable amount of our business is European, in other words, U.K. generally. I would say that's about 40%-45% of our revenue. Another as well. Those are our three main markets at the moment. Okay, thanks. Thank you. Thank you, Scott. The next question is from Andrew Renault at National Bank Financial. You're on mute. You're on mute, Andrew. Yeah. Yeah, two years later, I did it anyway. Sorry about that. No, what I was asking is, I mean, it's great you're starting iCBT. That's an easy, you know, launch internationally. I was wondering if you can talk a little bit about the regulatory environment of, let's say, for primary care or even mental health or the EAP in the other markets where Tictrac is. Yeah. I'll take this one. You know, as you know, Andrew, healthcare is one of the most regulated industries out there. You know, when you dive a little bit deeper, it really depends which area of healthcare you're playing in. If you think about primary care, you know, here in Canada, we've talked in the past how it is 13 different healthcare markets because it's the provinces and territories that have the jurisdiction. Even for us, you know, when we started the business to get out of Quebec and Ontario, it took us a couple of years. Then when we look at the U.S., it's you know, 50 different markets. When you look at Germany, it's 60 different federal states. It is a very complex regulatory environment. That's why in the past, when we've talked about international expansion, we said we will probably not do primary care outside of Canada, at least in the short term, because we just don't feel like the regulatory environment makes sense. We've always said that we're gonna expand internationally, you know, we're in wellness services and other less regulated areas, and this is exactly what we're doing today. This is not a no regulation segment of the market. It's a low regulation. There's always regulation, especially around data privacy, you know, where the data is hosted. It's not the same kind of regulatory environment where you have the physician colleges and the nurse colleges involved and all of these professional bodies. You know, priority number one is to bring wellness into Canada. As we've said, you know, we have 2 million members, and we have a large install base of direct customers and insurance partners that are very interested in this product. Then, you know, looking a little bit more in the long term, internationally, we're obviously going to approach all of Tictrac's customers with our iCBT products. We've already had some positive conversations. I think there's excitement there. When you look at the number of members and the coverage of some of these giant insurance companies that Tictrac has a good relationship with, it just paints a picture of the potential. Don't forget that we're not stopping here, right? Today we have primary care, mental health, including iCBT, EAP, and now wellness in Canada and OHS in Germany. We're gonna continue adding new products. As we add new products, one of the priorities is to say what products will fit into our install base. Now today, our install base has significantly changed. The lens with which we look at new opportunities has now really expanded. Yeah. No, that's fantastic color. Thank you, Cherif. One more, a bit of a follow-up, but a bit more on the geography side. As you're focusing on English and German-speaking markets, iCBT, you bought an Australian company. I mean, can you talk a little bit about does Tictrac have a presence over there? Are there any opportunities for legislative quick synergies in that market specifically? Sure. I'll take the localization question first, and I'll let Martin add comments about Australia. You are right that we focus on English-speaking markets, but don't forget that in Canada, you know, we're already bilingual with all of our services. We've already started the work of translating Tictrac's content into French. That being said, Tictrac's content is available in multiple other languages. I think they're in high single digits number of languages. And, you know, they have clients and partners all over Europe and Asia. So you can expect, you know, the localization to be done there. One of Tictrac's biggest strength is that you're able to customize content, programs, challenges, at a regional market level, but also at a micro level, where you get into a company or even a department. As you can imagine, like some of the big employers we work with, they have folks in different countries speaking different languages, you know, especially in Europe, right? It's many languages there. Localization is gonna be a very important part of our path. Obviously, the better we do this, the better we'll compete with local players. Martín, I'll let you comment about Australia. Yeah. Just further to what Cherif was saying, one of the things that we focus on, because we've been an international business from the beginning, is making sure that we're always culturally relevant in every market that we operate. It's not just language translation, it's a lot of cultural nuance, food recommendations, imagery. Entering the market, for instance, in Canada with Québécois is something that while we do have a platform in French, actually, modifying it for Québécois French and for local cultural nuances is key 'cause it needs to be locally homegrown, so to speak. We do have a lot of experience in doing that, even in countries, in locations like Hong Kong. Further to your question around Australia, while we aren't present in Australia, we are entering the market through one of our insurance partners with whom we've had tremendous success already in Asia and has introduced us to their counterparts within the same company there. We do expect within the next 12 months to make an entry there, at least through that insurer. That can be a good step for us. That's great, color. Thank you, and congrats again. Thanks. Thanks, Andrew. Thank you, Andrew. The next question is from David Kwan at TD Securities. Hi, guys. Congratulations on the acquisition. I'm wondering just as it relates to the cross-selling opportunity, you talked about selling Tictrac's offering into your Canadian customer base. Just what you talked about, I guess, the CAD 8 million-CAD 10 million in revenue expected over the next few years. What percentage of your customers right now have a health and wellness offering similar to Tictrac? I'm just trying to get a sense of what the greenfield opportunity is for you guys here and what the potential sales cycle is. Yeah. David, when we did the synergy analysis, we looked at our entire portfolio of customers. Although we don't have specific data on which one of our customers already subscribed to a wellness offering, we know that customers want an integrated solution to offer to their members. I think there's a clear need that the employers are favoring a single vendor and a single platform solution. When we did our synergy analysis, we looked at the opportunity of upselling and cross-selling a wellness service to our existing customers. Similar to what we do with EAP, when we launched our EAP service, we're now displacing other EAP vendors, and employers are opting for our integrated approach. We expect a similar approach. When we sell wellness, whether they have a wellness offering right now or not, and that's where we estimated the synergy revenue synergies of CAD 8 million-CAD 10 million over the next three years. I'll add to that, Navaid, is that the penetration of wellness services into our install base is very low. So when you contrast that with EAP, you know, EAP almost has a 100% penetration, and therefore, every case that we win is essentially a displacement of somebody else. In wellness, it is mostly gonna be greenfield. There's obviously pros and cons to that. The pro is that, you know, you're not displacing anybody, they're not waiting for a contract to end, et cetera. But the con, you know, for us to be cognizant of the pros and cons is that, you know, sometimes it's a new budget, right? When you compare and you contrast these two kind of go-to-market opportunities, there's puts and takes. Overall, the conversations we've had with our large employers and insurance partners have been very positive. Obviously, as you know, these are long sales cycles, nothing gets done in a day, you know, given the nature of the size of these customers, but it's been super positive. Great. Thanks, guys. One more question. Just on the integration work that's involved to integrate Tictrac platform into IHP. Can you talk about, you know, what types of challenges do you see and the timeline in terms of when you expect it to be fully integrated into the IHP? Yeah. I'll start with that. The technical challenge of integrating, you know, having one app, you know, on the front end and one kind of admin interface on the back end is a big one. As we said, you know, if we were to just acquire Tictrac and sell just Tictrac, it would make our lives much easier. But that is not our core strategy. That is not the ethos of Dialogue. From a technical point of view, it is more complicated, and it takes more time. The good news though is that the stack on which Tictrac was built is very similar, very complementary to ours, and it's built on an open API and microservices platform that makes it very easy to interact. When Alexis, our CTO, was over there just two weeks ago, he came back and he said, "You know, I'm blown away by how many similar decisions the two teams have taken over the last five years without knowing each other," and this makes the integration much easier. In terms of a timeline, we foresee the two platforms and all of the apps being fully integrated in the next 12 months. It doesn't mean that we will wait a full year to start selling it, but the full, you know, version 1.0 integration will take almost a year. That's for it to be, you know, perfect. Cherif, if I can just add one comment to that. Because we've got an API service that is commercialized today, and we've got a lot of experience already integrating our API as a series of microservices into services like Pulse in Asia, credentials product, our teams are very familiar with the requirements to integrate into existing products and have already been in those discussions and doing some of that work with the Dialogue team. So we're very confident in that ability because we've done it a number of times. Yeah. That's fine. Thanks, guys. Thank you. Thank you, David. Thank you, David. The next question is from Chelsea Stellick at iA Capital Markets. Good morning. Congratulations on the acquisition. I just have a quick question on, you know, I know you mentioned that there's gonna be a rollout of price hikes in 2022. I'm just curious how this is going to affect that pricing hikes rollout. Yeah. We don't foresee this having a large impact on the price increases that we're considering. I mean, this is the pricing of Tictrac, you know, as we sign up new customers, of course, will be adjusted. As you've seen, the growth margins are such that, you know, we're not trying to optimize 1% or 2% out of the operations. They're very healthy SaaS-like margins. I think what Tictrac and the team have done really well is to command a really good, you know, pricing power in the market. They're, like us, a premium provider. If you're looking for the cheapest telemedicine or virtual care company, it's not Dialogue. If you're looking for the cheapest wellness partner, it's not Tictrac. That's why, you know, from a brand and positioning point of view, we're joining two premium companies. We foresee that we're gonna have, you know, pretty good pricing power to go. Obviously, there's always risk there. We're always gonna keep you updated transparently on how we see the puts and takes going forward. Thank you. Just one quick follow-up. In terms of your, you know, integrating over the year, do you anticipate there's just gonna be a longer pause per se in the M&A, or if you foresee yourself still, you know, adding or looking at M&A opportunities for chronic disease or other opportunities this year or next year? Yeah. We have a core dev team that is very good and they're—I'm not foreseeing giving them any vacation the next few weeks and months, so they're gonna continue adding, you know, to the pipeline. We have a pretty robust pipeline, several interesting discussions. We don't wanna rush it. Again, this is not—you know, this is not just collecting assets and building a conglomerate. This is about integrating into the IHP. It is gonna take some time to do it properly with Tictrac. Hopefully, you know, in the next few months we'll do more. There's no specific timeline. I mean, if we find the perfect opportunity at the right price with the right team tomorrow, we'll go for it. If it takes another 12 or 18 months, that's also fine. We wanna do it well, and we wanna be very careful and kind of prudent in how we approach M&A. Okay. Well, it sounds like you'll be in the U.K. a lot, at least, so you know. All right. Thank you so much. Looking forward to it. Thanks. Thanks, Chelsea. Thank you, Chelsea. The next question is a follow-up from Andrew Renault, National Bank Financial. Hey, thank you for the follow-up. So just for me, Cherif, you mentioned, wellness being a greenfield and, budget being the main kind of concern. It's something that we've heard from, content producers as well. Have you contemplated, especially in your synergy analysis, any potential, cannibalization, let's say, of services or, one of your clients they're saying, "Well, you know, we'll try wellness, but maybe we'll remove something that you already have." Any thoughts around there? It has not come up yet in any of the discussions we've had, the idea of cannibalizing some of our own services. There is. You know, I think you're right. I mean, there is, I think, PMPM fatigue in the sense that, you know, as an HR manager, you're being pitched every day by different companies with different, you know, cool services. You know, you're adding CAD 2, CAD 3, CAD 5, CAD 6 bucks here and there, and it adds up. We certainly feel it as an employer. You can't just keep adding new services every day. That being said, when you offer something that has high ROI, and you're able to demonstrate the health outcomes, and you're able to go from a nice to have to a must-have, you're really able to have that pricing power and change those conversations from a cost or a price to a value conversation. This is what we've been seeing so far. One of the reasons we really like Tictrac is because really this is not a fluffy wellness company. This is one that's backed by science, and they have very robust kind of ROI and outcomes data that we've been very impressed with. And we think it's gonna be key to selling it to our customers and partners. No, that's great. Thank you. Thanks, Andrew. Thanks, Andrew. These are all the questions we have today. Thank you for your participation. We look forward to speaking with you again during our Q1 results on May 10th. Have a nice day, everybody. Thank you. Bye-bye.